NCT06675110 (QuEST) is a clinical trial in Scrub Typhus, sponsored by University of Oxford.

Who is sponsoring NCT06675110?

NCT06675110 is sponsored by University of Oxford.

What condition does NCT06675110 study?

NCT06675110 studies Scrub Typhus.

Is NCT06675110 still recruiting?

NCT06675110 is currently recruiting now. Last updated 12 January 2026.

Last reviewed 2026-01-12 · How we verify

NCT06675110: QuEST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

QuEST - Quick and Easy Scrub Typhus Diagnostic Tools

Recruiting now Last updated 12 January 2026

What this trial tests

trial in Scrub Typhus in 100 participants. Currently enrolling.

Timeline

17 July 2024

Primary endpoint
31 March 2026

30 April 2026

Quick facts

Lead sponsor	University of Oxford
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	17 July 2024
Primary completion	31 March 2026
Estimated completion	30 April 2026
Sites	1 location across Thailand

Conditions studied

Scrub Typhus — all drugs for Scrub Typhus →

Sponsor

University of Oxford

Who can join

7 and older, any sex, with Scrub Typhus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the performance of insulated isothermal polymerase chain reaction (iiPCR) in the diagnosis of scrub typhus in Chiang Rai Province

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Scrub Typhus

Currently open trials in the same condition.

NCT03274869 — Scrub Typhus Infection Induced Cardiovascular Disease · active not recruiting

Other University of Oxford trials

Trials by the same sponsor.

NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06675110 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oxford
Last refreshed: 12 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06675110.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing